Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


CIMA Labs, Inc. (now Teva Pharmaceuticals)

Acquired by Teva, CIMA drug delivery expertise included R&D, formulation, manufacturing and packaging and taste-masking technology.

Search Projects

  • Head, Business Development and Finance
  • Vice President, Commercial Operations